SnoreSounds

Otolaryngology (ENT) Pulmonology Sleep Medicine

Regulatory Status Disclosed

Overview

SnoreSounds by Appian Medical is an artificial intelligence (AI) tool designed for the analysis of nocturnal sounds. It is intended for use by sleep specialists, pulmonologists, otolaryngologists, and primary care physicians in both hospital and outpatient settings.

  • What it does: SnoreSounds processes audio recordings captured during sleep to identify and characterize snoring and other respiratory sounds. The AI algorithms analyze sound patterns to differentiate between various types of nocturnal sounds.
  • Who it is for: The tool is relevant for specialties involved in the diagnosis and management of sleep-disordered breathing, including sleep medicine, pulmonology, and ENT. It can also be utilized in primary care for initial screening or monitoring.
  • How it fits a clinical or practice workflow: SnoreSounds integrates into a clinical workflow by providing an objective analysis of nocturnal sounds, which can supplement patient history and other diagnostic tests. It can be used as a screening tool to identify patients who may benefit from further evaluation for sleep apnea or other sleep disorders. The output from SnoreSounds can aid physicians in making informed decisions regarding patient management and referral.
  • Notable capabilities: The system’s notable capabilities include its ability to differentiate between various sound types and provide a detailed acoustic analysis of a patient’s sleep.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Smartphone-based snore recording and analysis
  • Validated neural network algorithm for OSA diagnosis
  • Aids in self-diagnosis of Obstructive Sleep Apnea (OSA)
  • mHealth diagnostic technology

Use Cases

  • Initial screening for Obstructive Sleep Apnea (OSA)
  • Patient self-assessment of snoring and potential OSA
  • Monitoring of snoring severity over time

What Physicians Need to Know

Stroke Detection Speed
AI stroke detection systems can analyze CT scans in 1-6 minutes, which is significantly faster than traditional radiology workflows (15-60 minutes). This can cut door-to-notification time by 30-52% in real-world hospital settings. Some AI tools can detect stroke symptoms in under two minutes. Mobile applications are also being developed to recognize stroke symptoms in real-time, with some detecting facial asymmetry in nearly 100% of patients and arm weakness in over two-thirds of cases.
Brain MRI/CT Analysis
AI is transforming neuroimaging by automating tasks, increasing productivity, enhancing reporting accuracy, and rapidly identifying critical abnormalities. AI tools can detect acute intracranial hemorrhage in CT images within seconds and automatically triage these cases. For MRI, AI can drastically reduce the time needed to determine lesion volume (e.g., in multiple sclerosis) down to 3 seconds, providing precise quantitative measurements. AI models can read brain MRIs and diagnose neurological conditions with up to 97.5% accuracy in seconds, also predicting treatment urgency. AI can also be used to interpret brain MRIs, identifying key structures like gray matter, white matter, ventricles, and blood vessels, and explaining potential abnormalities in plain language. Some AI tools offer online MRI/CT analysis, providing plain language explanations, marking findings on images, and offering radiologist verification.
EEG Interpretation AI
AI is being used for automated interpretation of clinical electroencephalograms (EEGs), particularly in identifying epileptiform abnormalities and distinguishing between normal and abnormal recordings. AI models can evaluate EEG recordings in 16-second windows and then integrate these into a whole recording level to provide a bottom-line result. AI in EEG analysis enhances the detection of sleep disorders like obstructive sleep apnea (OSA) and facilitates real-time monitoring solutions. AI models can achieve high accuracy (e.g., 98.8%) in classifying sleep-related breathing events by combining non-linear features from EEG and ECG signals.
Seizure Detection
AI platforms can detect epileptic seizures from scalp EEG in real-time, offering live monitoring and instant seizure alerts via push notifications. Smartwatch applications are also being developed to accurately detect tonic-clonic seizures with a low rate of false alarms, achieving up to 98% sensitivity. AI systems are being developed to analyze neurobiological data from wearable devices to identify individual-specific seizure triggers and provide early warnings. AI can also help distinguish epilepsy from psychogenic non-epileptic seizures (PNES) using clinical notes from electronic health records, with high accuracy.
Neurodegenerative Disease Screening
AI is being applied to neuroimaging data to enhance the analysis of neurodegenerative diseases like Alzheimer's and Parkinson's. AI-powered tools can detect and segment white matter hyperintensities (WMH) for earlier and more accurate diagnosis of neurodegenerative diseases. AI can analyze breathing patterns during sleep to detect Parkinson's disease with nearly 80% accuracy. Deep learning approaches are used to improve the diagnosis and prognosis of Parkinson's disease using MRI and PET imaging.
Large Vessel Occlusion Detection
AI tools can auto-detect suspected large vessel occlusions (LVOs) within seconds of image acquisition, with 90% of alerts reviewed by specialists within 5 minutes. AI stroke detection systems achieve 90-95% accuracy for identifying LVOs. The incorporation of AI software for LVO detection in acute ischemic stroke can enhance workflow efficiency and decrease time to treatment. Some AI platforms demonstrate high sensitivity (e.g., 98%) and specificity (e.g., 94%) in detecting LVOs. AI tools have shown to improve radiology CT angiography report turnaround times for LVO detection.
Triage Prioritization Speed
AI imaging triage systems prioritize, schedule, and provide feedback on imaging requests, optimizing workflow and reducing wait times. These systems can automatically analyze CT angiography images to detect LVOs and transmit notifications, significantly reducing transfer times for stroke patients. AI can streamline clinical care and improve workflows without sacrificing accuracy. AI-powered solutions can enhance workflow efficiency by automating the detection and triage of critical conditions, enabling faster clinician response.
Mobile Notification System
Mobile applications are being developed to detect stroke symptoms in real-time and prompt users to call emergency services. AI-powered apps can detect seizures using smartwatch sensors and send automated messages or calls to emergency contacts if the user doesn't respond. Seizure detection platforms offer instant seizure alerts via push notifications to patients, families, and clinicians. Some AI systems leverage ambient monitoring via built-in cameras, motion sensors, and virtual assistants on personal devices to detect stroke symptoms and alert users and relatives.
Physician Tip

AI tools in neurology and neuroimaging offer significant advancements in speed and accuracy for diagnosis and triage. For stroke, AI can rapidly analyze imaging for LVOs and hemorrhages, significantly reducing door-to-notification and treatment times. Utilize these tools for efficient prioritization of critical cases, but always maintain clinical oversight for final diagnostic and treatment decisions. For EEG interpretation, AI can assist in identifying abnormalities and sleep disorders, potentially aiding in quicker diagnoses. In seizure detection, AI-powered mobile and wearable devices can provide real-time monitoring and alerts, which can be invaluable for patient safety and management. For neurodegenerative diseases, AI can assist in early screening and monitoring disease progression through advanced image analysis and even non-invasive methods like breathing pattern analysis. Integrate these AI insights into your clinical workflow to enhance efficiency and patient care, while critically evaluating the AI's output in the context of the full clinical picture.

AI solutions in neuroimaging are designed to integrate seamlessly with clinical radiology workflows, providing value without requiring additional keystrokes or mouse-clicks. They can integrate results directly into hospital Radiology Information Systems (RIS). AI-based imaging triage systems are maturing and integrating with hospital information systems and other clinical platforms. Some AI tools are compatible with existing clinical EEG hardware via standard data export. Mobile applications often transmit data to cloud platforms for real-time analysis. Data can be imported from various sources like CDs, USBs, files, or portals for AI analysis. Secure sharing of AI-generated reports with neurologists or healthcare providers is also a feature.

Details

Category Neurology AI, Wearables & Remote Monitoring (RPM)
Pricing Unknown
DeploymentMobile App
Mobile App1
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated
Integrations
EHR Not specified
Specialties Otolaryngology (ENT), Pulmonology, Sleep Medicine

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2015-11-05K150102 510(k)SnoreSounds

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate SnoreSounds

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for SnoreSounds.

View all on YouTube

Frequently Asked Questions

SnoreSounds is a software intended to aid in the diagnostic evaluation of snoring. It provides quantitative and qualitative analysis of snoring sounds. By analyzing snore sounds, it can help differentiate between simple snoring and snoring associated with obstructive sleep apnea (OSA), and even estimate OSA severity.
While SnoreSounds can detect OSA with reasonable accuracy, especially with sex-specific models, it is not a definitive diagnostic tool on its own. Snore loudness alone may not accurately indicate OSA severity, as it can be influenced by breathing effort and airway obstruction. Additionally, the software's accuracy can be affected by factors like noise reduction techniques and the quality of recordings.
SnoreSounds software is an FDA 510(k) cleared medical device. This means it has been reviewed by the FDA and determined to be substantially equivalent to another legally marketed device. Compliance with regulations like 21 CFR 801 for labeling is required.
Physicians can utilize polysomnography (PSG), the gold standard for OSA diagnosis, or home sleep testing (HST). Other options include oral appliances, CPAP machines, and in some cases, surgical interventions. There are also other anti-snoring devices like nasal dilators and smart pillows, though their effectiveness varies depending on the cause of snoring.
The provided information does not contain specific pricing details for SnoreSounds for medical professionals or clinics. However, for similar medical devices used to treat sleep apnea, insurance coverage often applies as a medical device, not dental.
The provided information does not explicitly detail SnoreSounds' approach to data privacy and security. However, for similar applications that record audio, privacy policies often state that recordings are stored locally on the device, are not collected by the developer, and personally identifiable information is not gathered. When data is shared for research or with medical professionals, explicit consent is typically required, and data may be anonymized or aggregated.
SnoreSounds provides quantitative and qualitative analysis of snoring sounds, and research indicates that acoustic analysis of snoring can carry information related to the site and degree of upper airway obstruction. High-frequency snore signals may indicate greater OSA or obstruction by the tongue base or tonsil, while low-frequency sounds are typical of soft palatal obstruction. AI-based acoustic phenotyping is also being explored to classify the excitation location of snore sounds in the upper airway.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-03 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.